In conclusion, this study provides a molecular basis for a novel role of genistein in simultaneously inhibiting the activation of STAT3 and other closely related oncogenic kinases, such as AKT, ERK, and p38, in prostate cancer DU145 cells (Figure 6). This evidence concerns the gene STAT3 and Familial prostate cancer.